Cited by 208Cancer survivorship and careChildhood Cancer Survivors' Quality of LifeGlobal Cancer Incidence and Screening

ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe

Open access
Vaz-Luis, I., Masiero, M., Cavaletti, G., Cervantes, A., Chlebowski, R.T., Curigliano, G., Felip, E., Ferreira, A.R. +20 more·2022·Annals of Oncology

Abstract

Background The increased number of cancer survivors and the recognition of physical and psychosocial challenges, present from cancer diagnosis through active treatment and beyond, led to the discipline of cancer survivorship.Design and methods Herein, we reflected on the different components of survivorship care, existing models and priorities, in order to facilitate the promotion of high-quality European survivorship care and research.Results We identified five main components of survivorship care: (i) physical effects of cancer and chronic medical conditions; (ii) psychological effects of cancer; (iii) social, work and financial effects of cancer; (iv) surveillance for recurrences and second cancers; and (v) cancer prevention and overall health and well-being promotion. Survivorship care can be delivered by structured care models including but not limited to shared models integrating primary care and oncology services. The choice of the care model to be implemented has to be adapted to local realities. High-quality care should be expedited by the generation of: (i) focused and shared European recommendations, (ii) creation of tools to facilitate implementation of coordinated care and (iii) survivorship educational programs for health care teams and patients. The research agenda should be defined with the participation of health care providers, researchers, policy makers, patients and caregivers. The following patient-centered survivorship research areas were highlighted: (i) generation of a big data platform to collect long-term real-world data in survivors and healthy controls to (a) understand the resources, needs and preferences of patients with cancer, and (b) understand biological determinants of survivorship issues, and (ii) develop innovative effective interventions focused on the main components of survivorship care.Conclusions The European Society for Medical Oncology (ESMO) can actively contribute in the efforts of the oncology community toward (a) promoting the development of high-quality survivorship care programs, (b) providing educational material and (c) aiding groundbreaking research by reflecting on priorities and by supporting research networking.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.annonc.2022.07.1941

Cites

123 of 123 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The creation of new care pathway delivery methods and provision of novel technologies and infrastructures to support self-management have been flagged as research priorities in survivorship care.

    “The creation of new care pathway delivery methods and provision of novel technologies and infrastructures to support self-management have been flagged as research priorities in survivorship care.9,48”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vaz-Luis, I., Masiero, M., Cavaletti, G., Cervantes, A., Chlebowski, R. T., Curigliano, G., Felip, E., Ferreira, A. R., Ganz, P. A., Hegarty, J., Jeon, J., Johansen, C., Joly, F., Jordan, K., Koczwara, B., Lagergren, P., Lambertini, M., Lenihan, D., Linardou, H., Loprinzi, C., Partridge, A. H., Rauh, S., Steindorf, K., van der Graaf, W., van de Poll-Franse, L., Pentheroudakis, G., Peters, S., & Pravettoni, G.
Affiliations
  • University of Milan (IT)
  • University of Milano-Bicocca (IT)
  • Universitat de València (ES)
  • The Lundquist Institute (US)
  • Vall d'Hebron Hospital Universitari (ES)
  • Champalimaud Foundation (PT)
  • University of California, Los Angeles (US)
  • University College Cork (IE)
  • Yonsei University (KR)
  • University of Copenhagen (DK)
  • Centre François Baclesse (FR)
  • Heidelberg University (DE)
  • Flinders University (AU)
  • Karolinska Institutet (SE)
  • Ospedale Policlinico San Martino (IT)
  • Metropolitan Hospital (GR)
  • Mayo Clinic (US)
  • Harvard University (US)
  • German Cancer Research Center (DE)
  • European Society for Medical Oncology (CH)
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2022-11
Volume
33
Issue
11
Pages
1119-1133
ISSN
0923-7534 (ISSN-L)
OpenAlex
W4291396120
Cited by
208
References
123
Citations by year
2026: 61 · 2025: 52 · 2024: 55 · 2023: 33 · 2022: 5 · 2019: 1
FWCI
15.16
Type
journal article
Language
en
Open access
Locations
  • Annals of Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • HAL (submittedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Funders
European Society for Medical Oncology
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords
cancer survivorship, survivorship care, survivorship care models, cancer surveillance, secondary malignancies, cancer prevention, patient-oriented research, real-world data, survivorship education, research priorities, ESMO
MeSH terms
Cancer Survivors, Survivorship, Europe, Humans, Medical Oncology, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review